Showing 541 - 560 results of 1,171 for search 'antibody effect function', query time: 0.11s Refine Results
  1. 541

    Human anti-D immunoglobulin preparations: potency standardisation milestones by N. S. Vildanova, E. S. Kormshchikova, E. N. Kalinina, K. A. Vorobiev, I. V. Paramonov, E. Yu. Kudasheva

    Published 2022-10-01
    “…The effectiveness of immune suppression is a direct function of the active ingredient dose received with the medicinal product. …”
    Get full text
    Article
  2. 542

    First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report by Isabelle Kwiedor, Martina Menacher, Monika Ellßel, Markus Naumann, Antonios Bayas

    Published 2024-12-01
    “…This rapid response was accompanied by a marked reduction in AChR antibody level by 89.8% within 4 weeks. This case supports the potential of efgartigimod as a fast-acting and effective treatment option for managing iMC, offering an alternative to existing therapies.…”
    Get full text
    Article
  3. 543

    Serologic Presentation of Lamotrigine-Induced Lupus by Hannah Dempsey, Gabriella Aitcheson, Gretchen Goble, Riley Snook

    Published 2022-01-01
    “…Initial workup revealed acute pancreatitis, elevated liver function enzymes (LFTs), and abnormal anti-double-stranded DNA antibody (anti-dsDNA) 1 : 640. …”
    Get full text
    Article
  4. 544

    Optimizing clinical outcomes: The journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation by Angie H. Fares, Ankit K. Desai, Laura E. Case, Cassie Sharon, Amy Klinepeter, Amelia Kirby, Matthew T. Lisi, Rebecca L. Koch, Priya S. Kishnani

    Published 2024-12-01
    “…Enzyme replacement therapy (ERT) with alglucosidase-alfa is lifesaving, but its effectiveness is influenced by the patient's cross-reactive immunologic material (CRIM) status, dose of ERT, and the development of high antibody titers, which can reduce the therapy's efficacy. …”
    Get full text
    Article
  5. 545

    CXCL16 Induces the Progression of Pulmonary Fibrosis through Promoting the Phosphorylation of STAT3 by Sheng Zuo, Zhen Zhu, Yi Liu, Hong Li, Shuang Song, Shaojun Yin

    Published 2019-01-01
    “…The aim of present study is to examine the function of CXCL16 in PF. Materials and Methods. In this study, we constructed the PF model on mouse by using bleomycin and analyzed the effect of the mouse recombinant protein CXCL16 on mouse lung fibroblast L929 (LF) as well. …”
    Get full text
    Article
  6. 546

    Tissue eosinophilia induced by recombinant human interleukin-5 in the hamster cheek pouch membrane by M. Minnicozzi, W. N. Durán, D. Kim, G. J. Gleich, J. Wagner, R. W. Egan

    Published 1995-01-01
    “…Interleukin-5 (IL-5) is a cytokine that preferentially effects the development and function of eosinophils, and is considered important in the pathophysiology of allergic inflammation. …”
    Get full text
    Article
  7. 547

    Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice by E. L. Nasonov, T. V. Popkova, A. M. Lila

    Published 2021-09-01
    “…Currently, strong evidence has been obtained for the fundamental role of pathological activation of B cells in the pathogenesis of immunoinflammatory (autoimmune) rheumatic diseases (IMRD), and drugs that specifically modulate the function or cause depletion of various subpopulations of B cells and plasma cells are considered a promising direction. pharmacotherapy of these diseases. of particular interest is belimumab (BLM), a human monoclonal antibody (mAb) (IgG1λ) to BAFF (B cell-activating factor belonging to the TNF family), which is the first “targeted” biological drug specially developed for the treatment of systemic lupus erythematosus (SLE). …”
    Get full text
    Article
  8. 548

    Analysis of influencing factors on Turner syndrome combined with autoimmune thyroid disease by Yingmei Cen, Wei Wei, Yinchun Huang, Yiying Qi, Gendie E. Lash, Li Li

    Published 2025-08-01
    “…The effects of age, body mass index (BMI), karyotype, fasting insulin, blood lipids and other factors that may affect thyroid function were analyzed, and the possible risk factors associated with AITD in TS patients explored.ResultsOf the 63 TS patients, 24 (38.10%) had normal thyroid function and 39 (61.90%) patients had TgAb and/or TPOAb. …”
    Get full text
    Article
  9. 549

    Interleukin 17A inhibitor secukinumab in the treatment of patients with psoriatic arthritis by N. A. Shostak, D. Yu. Andriyashkina, A. S. Dvornikov, N.  M. Babadaev, D. V. Somov

    Published 2022-10-01
    “…Secukinumab is the first antibody against IL 17 approved in many countries for PsA treatment in adult patients. …”
    Get full text
    Article
  10. 550

    Proteomics and transcriptomics combined reveal specific immunological markers in autoimmune thyroid disease by Xia Chen, Hui Chen

    Published 2025-01-01
    “…Enrichment analysis revealed that these differentially expressed genes and proteins are primarily associated with immune function, antigen-antibody binding, and alterations in immune cells. …”
    Get full text
    Article
  11. 551

    Research status and prospects of psycho-vaccine by DAI Qin, DAI Zongpei

    Published 2025-04-01
    “…There still exist some problems in the current research of psycho-vaccine, including uncertain specificity, unclear threshold of natural stress vaccination, uncertain chain-relationship of psycho-virus—psycho-vaccine—psycho-antibody, and unclear effect of novel psycho-vaccination. …”
    Get full text
    Article
  12. 552

    Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis by Ningjun Shao, Lingxiong Chai, Xu Bai, Qun Luo

    Published 2025-08-01
    “…Concurrently, MPO-ANCA titers decreased from 1:1280 to 1:80, and pulmonary infiltrates resolved. However, renal function remained impaired (serum creatinine: 229 µmol/L) due to irreversible fibrosis.ConclusionsThis case demonstrates RTX’s dual efficacy in suppressing autoimmunity and alleviating anemia, potentially through indirect effects on inflammatory pathways and iron metabolism. …”
    Get full text
    Article
  13. 553

    Efficacy of selenium supplementation for patients with Graves' hyperthyroidism during methimazole treatment: protocol for a systematic review and meta-analysis by Mingxing Li, Shuo Yuan, Qing Wen

    Published 2024-09-01
    “…The Cochrane Collaboration’s risk of bias tool will be used to assess the quality of all included studies, and the baseline data of all the studies are extracted by the authors. A random-effects model or a fixed-effects model is used to analyse the outcomes. …”
    Get full text
    Article
  14. 554

    Research on the Targeted Treatment of Squamous Cell Carcinoma by Nanographene Drug Delivery System by Xiangyu Zhang, Liwei Guo, Zhenbang Sun, Deming Han, Lihui Zhao

    Published 2023-01-01
    “…Results showed that the NGO-PEG-BPEI-CDDP-Antibody complex had a significant antitumor effect and was able to enter the nude mice and targeted squamous cell carcinoma cell and effectively kill squamous cell carcinoma cells, thus reducing the use of clinical chemotherapeutic drugs, improving the efficacy and providing a new answer for the treatment of squamous cell carcinoma.…”
    Get full text
    Article
  15. 555
  16. 556

    Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa. by Saidou Balam, Kazutoyo Miura, Imen Ayadi, Drissa Konaté, Nathan C Incandela, Valentina Agnolon, Merepen A Guindo, Seidina A S Diakité, Sope Olugbile, Issa Nebie, Sonia M Herrera, Carole Long, Andrey V Kajava, Mahamadou Diakité, Giampietro Corradin, Socrates Herrera, Myriam Arevalo Herrera

    Published 2025-01-01
    “…In addition, BALB/c mice were immunized with the rPvs48/45 protein formulated in Montanide ISA-51 and inoculated with a crude extract of P. falciparum NF-54 gametocytes to evaluate the parasite-boosting effect on rPvs48/45 antibody titers. Specific anti-rPvs48/45 IgG purified from African plasma was used to evaluate the ex vivo TB activity on P. falciparum, using standard mosquito membrane feeding assays (SMFA).…”
    Get full text
    Article
  17. 557

    Chronic colitis upregulates microRNAs suppressing brain-derived neurotrophic factor in the adult heart. by Yanbo Tang, Kevin T Kline, Xiaoying S Zhong, Ying Xiao, Haifeng Lian, Jun Peng, Xiaowei Liu, Don W Powell, Guodu Tang, Qingjie Li

    Published 2021-01-01
    “…Mechanistically, cellular experiments identified IL-1β as the inflammatory mediator upregulating cardiac miR-155; this effect was confirmed in adult rats. Furthermore, IL-1β neutralizing antibody ameliorated the DSS-induced increase in miR-155 and concurrent decrease in BDNF in the adult heart, showing therapeutic potential. …”
    Get full text
    Article
  18. 558

    Subclinical Myocardial Dysfunction in Pediatric and Adolescent Celiac Disease Patients: A Systematic Review and Meta-Analysis by Elpida Emmanouilidou-Fotoulaki, Maria Kavga, Michail Delis, Evangelia Farmaki, Charalampos Agakidis, Kyriaki Papadopoulou-Legbelou

    Published 2025-03-01
    “…<b>Background/Objectives:</b> This is the first systematic review and meta-analysis investigating early myocardial dysfunction in children/adolescents with celiac disease and the effect of a gluten-free diet by comparing early echocardiographic markers between patients and healthy individuals and between compliant and non-compliant celiac disease patients (based on serum antibody titers). …”
    Get full text
    Article
  19. 559

    Influence of Distinct Maternal Cytomegalovirus-Specific Neutralizing and Fc Receptor-Binding Responses on Congenital Cytomegalovirus Transmission in HIV-Exposed Neonates by Itzayana G. Miller, Aakash Mahant Mahant, Jennifer A. Jenks, Eleanor C. Semmes, Eric Rochat, Savannah L. Herbek, Caroline Andy, Nicole S. Rodgers, Justin Pollara, Linda M. Gerber, Betsy C. Herold, Sallie R. Permar

    Published 2025-02-01
    “…Recent work has identified potential immune correlates of protection against cCMV transmission including maternal and placentally transferred antibody levels and their function, which may inform the development of maternal active (vaccine) and passive (mono/polyclonal antibody) immunizations. …”
    Get full text
    Article
  20. 560

    Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis by Xiaoyu Huang, Zhouao Zhang, Zhouyi Wang, Tiancheng Luo, Mingjin Yang, Xinyan Guo, Xue Du, Tianyu Ma, Yong Zhang

    Published 2025-01-01
    “…Therefore, we aimed to identify potential novel therapeutic targets that preserve part of B cell function while inhibiting antibody-secreting cells (ASCs). …”
    Get full text
    Article